(Q42984292)

12 November 2017

An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection (English)

1 reference

12 November 2017

1 reference

1

Thio CL

1 reference

12 November 2017

7

Astemborski J

1 reference

12 November 2017

2

Goedert JJ

1 reference

12 November 2017

4

Vlahov D

1 reference

12 November 2017

3

Mosbruger T

1 reference

12 November 2017

8

Thomas DL

1 reference

12 November 2017

6

O'Brien SJ

1 reference

12 November 2017

Strathdee SA

5

1 reference

12 November 2017

1 June 2004

1 reference

12 November 2017

1 reference

12 November 2017

5

1 reference

12 November 2017

4

1 reference

12 November 2017

294-300

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gene.6364072

12 November 2017

0 references

cites work

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

HLA-Cw*04 and hepatitis C virus persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

The pathophysiology of tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Polymorphism of the 5'-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

Nucleotide diversity of the TNF gene region in an African village

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

IL-10 and TNF-α polymorphisms and the recovery from HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364072

7 January 2021

Identifiers

DOI

10.1038/SJ.GENE.6364072

1 reference

12 November 2017

1 reference

PubMed ID

15071492